Skip to main content

(Approval lapsed) Xylanaest 1% with Epinephrine 1:200,000 5ml ampoule (Gebro Pharma)

Section 19A approved medicine
(Approval lapsed) Xylanaest 1% with Epinephrine 1:200,000 5ml ampoule (Gebro Pharma)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0478 061 879
Approved until
Status
Expired
Medicines in short supply/unavailable
XYLOCAINE 1% WITH ADRENALINE 1:200,000 20mL injection vial - AUST R 12015
Indication(s)

Indicated for the production of local or regional anaesthesia by the following techniques:

  • infiltration,
  • intravenous regional anaesthesia - excluding solutions with adrenaline (epinephrine) acid tartrate,
  • peripheral nerve block such as intercostal block,
  • major plexus block such as brachial plexus block,
  • epidural block,
  • subarachnoid block.

Help us improve the Therapeutic Goods Administration site